Supplier News Breaks Archives

Week of Mon, Feb 13th, 2012

McNeil recalls Tylenol infant oral suspension

McNeil Consumer Healthcare is voluntarily recalling about 574,000 bottles of Infants' Tylenol Oral Suspension pain reliever/fever reducer, citing concerns about the syringe dosing system.

Mylan to rename specialty pharmaceuticals unit

Mylan Inc. plans to change the name of its branded specialty pharmaceutical business from Dey Pharma to Mylan Specialty.

Kellogg to buy Pringles from Procter & Gamble

Kellogg Co. plans to acquire the Pringles snack business from Procter & Gamble Co. for nearly $2.7 billion.

Perrigo rolls out store-brand Claritin-D 12

Perrigo Co. has begun shipping Loratadine-D 12-hour extended-release tablets for allergies.

Merck wins approval for glaucoma treatment

Merck has been cleared by the Food and Drug Administration to market Zioptan 0.0015%, which the company said is the first preservative-free prostaglandin analog ophthalmic solution.

Amylin ships Bydureon in U.S.

Amylin Pharmaceuticals Inc. has released Bydureon, which it called the first and only once-weekly treatment for type 2 diabetes, to U.S. pharmacies.

Crest adds to 3D White oral care roster

Procter & Gamble Co. has expanded its Crest 3D White oral care line with Crest 3D White Glamorous White Toothpaste and Crest 3D White Intensive Professional Effects Whitestrips.